United States Congress

Generics competition: change patent law over FAST Act, says expert

Generics competition: change patent law over FAST Act, says expert

By Fiona BARRY

As US Congress considers the FAST (Fair Access for Safe and Timely Generics) bill to tackle “smokescreens” preventing competition, an expert tells in-Pharmatechnologist.com the problems behind marketing exclusivity run deeper and could be solved with...